Your browser doesn't support javascript.
loading
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.
Bousquet, J; Bedbrook, A; Czarlewski, W; Onorato, G L; Arnavielhe, S; Laune, D; Mathieu-Dupas, E; Fonseca, J; Costa, E; Lourenço, O; Morais-Almeida, M; Todo-Bom, A; Illario, M; Menditto, E; Canonica, G W; Cecchi, L; Monti, R; Napoli, L; Ventura, M T; De Feo, G; Fokkens, W J; Chavannes, N H; Reitsma, S; Cruz, A A; da Silva, J; Serpa, F S; Larenas-Linnemann, D; Fuentes Perez, J M; Huerta-Villalobos, Y R; Rivero-Yeverino, D; Rodriguez-Zagal, E; Valiulis, A; Dubakiene, R; Emuzyte, R; Kvedariene, V; Annesi-Maesano, I; Blain, H; Bonniaud, P; Bosse, I; Dauvilliers, Y; Devillier, P; Fontaine, J F; Pépin, J L; Pham-Thi, N; Portejoie, F; Picard, R; Roche, N; Rolland, C; Schmidt-Grendelmeier, P; Kuna, P.
Afiliação
  • Bousquet J; 1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
  • Bedbrook A; INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny Le Bretonneux, France.
  • Czarlewski W; Euforea, Brussels, Belgium.
  • Onorato GL; 4Humboldt-Universität zu Berlin, Berlin Institute of Health, Comprehensive Allergy Center, Department of Dermatology and Allergy, Charité, Universitätsmedizin Berlin, Berlin, Germany.
  • Arnavielhe S; 1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
  • Laune D; Medical Consulting Czarlewski, Levallois, France.
  • Mathieu-Dupas E; 1MACVIA-France, Fondation Partenariale FMC VIA-LR, CHU Arnaud de Villeneuve, 371 Avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France.
  • Fonseca J; KYomed INNOV, Montpellier, France.
  • Costa E; KYomed INNOV, Montpellier, France.
  • Lourenço O; KYomed INNOV, Montpellier, France.
  • Morais-Almeida M; Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto, Medida, Lda Porto, Portugal.
  • Todo-Bom A; 8UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing, University of Porto (Porto4Ageing), Porto, Portugal.
  • Illario M; 9Faculty of Health Sciences and CICS - UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Menditto E; Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal.
  • Canonica GW; 11Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
  • Cecchi L; Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
  • Monti R; 13CIRFF, Federico II University, Naples, Italy.
  • Napoli L; 14Personalized Medicine Clinic Asthma and Allergy, Humanitas Research Hospital, Humanitas University, Rozzano, Milan, Italy.
  • Ventura MT; SOS Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy.
  • De Feo G; 16Department of Medical Sciences, Allergy and Clinical Immunology Unit, University of Torino & Mauriziano Hospital, Turin, Italy.
  • Fokkens WJ; Consortium of Pharmacies and Services COSAFER, Salerno, Italy.
  • Chavannes NH; 18Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
  • Reitsma S; 19Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
  • Cruz AA; Department of Otorhinolaryngology, Amsterdam University Medical Centre (AMC), Amsterdam, The Netherlands.
  • da Silva J; 21Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Serpa FS; Department of Otorhinolaryngology, Amsterdam University Medical Centre (AMC), Amsterdam, The Netherlands.
  • Larenas-Linnemann D; 22ProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Vitória da Conquista, Brazil.
  • Fuentes Perez JM; WHO GARD Planning Group, Salvador, Brazil.
  • Huerta-Villalobos YR; 24Department of Internal Medicine and Allergic Clinic of Professor Polydoro Ernani de Sao, Thiago University Hospital, Federal University of Santa Catarina (UFSC), Florianópolis, Brazil.
  • Rivero-Yeverino D; 25Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria, Vitória, Esperito Santo Brazil.
  • Rodriguez-Zagal E; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, Mexico City, Mexico.
  • Valiulis A; 27Hospital General Regional 1 "Dr Carlos Mc Gregor Sanchez Navarro" IMSS, Mexico City, Mexico.
  • Dubakiene R; 27Hospital General Regional 1 "Dr Carlos Mc Gregor Sanchez Navarro" IMSS, Mexico City, Mexico.
  • Emuzyte R; Allergist, Mexico City, Mexico.
  • Kvedariene V; Allergist, Mexico City, Mexico.
  • Annesi-Maesano I; 29Clinic of Children's Diseases, and Institute of Health Sciences Department of Public Health, Vilnius University Institute of Clinical Medicine, Vilnius, Lithuania.
  • Blain H; European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
  • Bonniaud P; 31Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
  • Bosse I; 32Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Dauvilliers Y; 33Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Devillier P; 34Epidemiology of Allergic and Respiratory Diseases, Department Institute Pierre Louis of Epidemiology and Public Health, INSERM, Sorbonne Université, Medical School Saint Antoine, Paris, France.
  • Fontaine JF; 35Department of Geriatrics, Montpellier University Hospital, Montpellier, France.
  • Pépin JL; 36EA 2991, Euromov, University Montpellier, Montpellier, France.
  • Pham-Thi N; 37CHU Dijon, Dijon, France.
  • Portejoie F; Allergist, La Rochelle, France.
  • Picard R; 39Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Montpellier, France.
  • Roche N; Inserm U1061, Montpellier, France.
  • Rolland C; 41UPRES EA220, Pôle des Maladies des Voies Respiratoires, Hôpital Foch, Université Paris-Saclay, Suresnes, France.
  • Schmidt-Grendelmeier P; Allergist, Reims, France.
  • Kuna P; 43Laboratoire HP2, Grenoble, INSERM, U1042, Université Grenoble Alpes, Grenoble, France.
Clin Transl Allergy ; 9: 16, 2019.
Article em En | MEDLINE | ID: mdl-30911372
ABSTRACT

AIMS:

Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases.

METHODS:

MASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients. STAKEHOLDERS Include patients, health care professionals (pharmacists and physicians), authorities, patient's associations, private and public sectors.

RESULTS:

MASK is deployed in 23 countries and 17 languages. 26,000 users have registered. EU GRANTS 2018 MASK is participating in EU projects (POLLAR impact of air POLLution in Asthma and Rhinitis, EIT Health, DigitalHealthEurope, Euriphi and Vigour). LESSONS LEARNT (i) Adherence to treatment is the major problem of allergic disease, (ii) Self-management strategies should be considerably expanded (behavioural), (iii) Change management is essential in allergic diseases, (iv) Education strategies should be reconsidered using a patient-centred approach and (v) Lessons learnt for allergic diseases can be expanded to chronic diseases.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_desigualdade_iniquidade / 1_recursos_humanos_saude Tipo de estudo: Guideline Aspecto: Equity_inequality Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_desigualdade_iniquidade / 1_recursos_humanos_saude Tipo de estudo: Guideline Aspecto: Equity_inequality Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
...